The Global Vascular Graft Market was valued at USD 3.6 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 7.3 billion by 2034.
The market expansion is driven by the rising prevalence of cardiovascular disorders, technological innovations, and the growing incidence of end-stage renal disease (ESRD), along with an increase in surgical interventions worldwide. Vascular grafts are medical devices designed to replace, repair, or bypass damaged or diseased blood vessels, restoring normal blood flow. These grafts are manufactured from synthetic materials, biological tissues, or a hybrid of both. They are widely used in treatments for cardiovascular conditions, aneurysms, and hemodialysis access. Recent advancements, such as bioengineered grafts, heparin-coated ePTFE grafts, and hybrid materials, enhance compatibility, reduce thrombosis risk, and improve long-term patency. The market is also benefiting from the growing preference for minimally invasive and endovascular procedures, increasing use of tissue-engineered and biodegradable grafts, adoption of drug-eluting and coated grafts, and expansion in emerging markets, collectively propelling industry growth.
The polyester grafts segment held a 62.3% share in 2024. Polyester grafts are preferred for their durability, excellent biocompatibility, and proven long-term patency in vascular repair and bypass procedures. Their extensive clinical history and consistent performance in aortic and peripheral bypass surgeries have earned them high trust among surgeons, making them a staple in vascular procedures.
The hemodialysis access segment is expected to grow at a CAGR of 6.3% through 2034. Rising cases of ESRD and an increasing number of patients requiring long-term hemodialysis are driving demand for vascular grafts. Innovations in graft design that improve patency and minimize infection risks further support growth in this segment.
North America Vascular Graft Market held a 32.2% share in 2024. High rates of coronary artery disease, peripheral artery disease, and aortic aneurysms contribute to the region’s strong demand. Well-established hospitals with specialized vascular surgery centers and access to advanced surgical technologies support the adoption of both open and endovascular graft procedures.
Key players in the Global Vascular Graft Market include Cook Medical, Gore, Terumo, Medtronic, B. Braun, Merit Medical Systems, LeMaitre, Abbott, Endologix, Vascular Graft Solutions, MicroPort, Artivion, BD (Becton, Dickinson & Company), Getinge, and Cordis. Companies in the Vascular Graft Market are adopting multiple strategies to strengthen their market position. They are heavily investing in research and development to create innovative grafts with improved patency, biocompatibility, and reduced complication risks. Strategic mergers, acquisitions, and partnerships help expand product portfolios and regional reach. Many firms focus on technological advancements, including drug-eluting, bioengineered, and hybrid grafts. Marketing campaigns, surgeon education programs, and strong hospital collaborations improve brand recognition and trust.
This product will be delivered within 2-4 business days.
The market expansion is driven by the rising prevalence of cardiovascular disorders, technological innovations, and the growing incidence of end-stage renal disease (ESRD), along with an increase in surgical interventions worldwide. Vascular grafts are medical devices designed to replace, repair, or bypass damaged or diseased blood vessels, restoring normal blood flow. These grafts are manufactured from synthetic materials, biological tissues, or a hybrid of both. They are widely used in treatments for cardiovascular conditions, aneurysms, and hemodialysis access. Recent advancements, such as bioengineered grafts, heparin-coated ePTFE grafts, and hybrid materials, enhance compatibility, reduce thrombosis risk, and improve long-term patency. The market is also benefiting from the growing preference for minimally invasive and endovascular procedures, increasing use of tissue-engineered and biodegradable grafts, adoption of drug-eluting and coated grafts, and expansion in emerging markets, collectively propelling industry growth.
The polyester grafts segment held a 62.3% share in 2024. Polyester grafts are preferred for their durability, excellent biocompatibility, and proven long-term patency in vascular repair and bypass procedures. Their extensive clinical history and consistent performance in aortic and peripheral bypass surgeries have earned them high trust among surgeons, making them a staple in vascular procedures.
The hemodialysis access segment is expected to grow at a CAGR of 6.3% through 2034. Rising cases of ESRD and an increasing number of patients requiring long-term hemodialysis are driving demand for vascular grafts. Innovations in graft design that improve patency and minimize infection risks further support growth in this segment.
North America Vascular Graft Market held a 32.2% share in 2024. High rates of coronary artery disease, peripheral artery disease, and aortic aneurysms contribute to the region’s strong demand. Well-established hospitals with specialized vascular surgery centers and access to advanced surgical technologies support the adoption of both open and endovascular graft procedures.
Key players in the Global Vascular Graft Market include Cook Medical, Gore, Terumo, Medtronic, B. Braun, Merit Medical Systems, LeMaitre, Abbott, Endologix, Vascular Graft Solutions, MicroPort, Artivion, BD (Becton, Dickinson & Company), Getinge, and Cordis. Companies in the Vascular Graft Market are adopting multiple strategies to strengthen their market position. They are heavily investing in research and development to create innovative grafts with improved patency, biocompatibility, and reduced complication risks. Strategic mergers, acquisitions, and partnerships help expand product portfolios and regional reach. Many firms focus on technological advancements, including drug-eluting, bioengineered, and hybrid grafts. Marketing campaigns, surgeon education programs, and strong hospital collaborations improve brand recognition and trust.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Raw Material, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Vascular Graft market report include:- Abbott
- Artivion
- B. Braun
- BD (Becton, Dickinson & Company)
- Cook Medical
- Cordis
- Endologix
- Getinge
- Gore
- LeMaitre
- Medtronic
- Merit Medical Systems
- MicroPort
- Terumo
- Vascular Graft Solutions
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | October 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 3.6 Billion |
| Forecasted Market Value ( USD | $ 7.3 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
